Busey Wealth Management Abbott Laboratories Transaction History

Busey Wealth Management

$3 Billion
Q3 2024

A detailed history of Busey Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Busey Wealth Management holds 93,059 shares of ABT stock, worth $10.8 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

93,059

Previous 93,140 0.09%

Holding current value

$10.8 Million

Previous $9.68 Million 9.62%

% of portfolio

0.35%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$100.07 - $118.13 $8,105 - $9,568	-81 Reduced 0.09%	93,059 $10.6 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $116,141 - $129,643	-1,153 Reduced 1.22%	93,140 $9.68 Million
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $29,460 - $32,538	269 Added 0.29%	94,293 $10.7 Million
Q4 2023 Jan 25, 2024	BUY	$90.19 - $110.4 $1.15 Million - $1.41 Million	12,740 Added 15.67%	94,024 $10.3 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $188,003 - $225,572	-1,968 Reduced 2.36%	81,284 $7.87 Million
Q2 2023 Jul 21, 2023	SELL	$100.78 - $112.29 $161,751 - $180,225	-1,605 Reduced 1.89%	83,252 $9.08 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $104,221 - $122,674	-1,076 Reduced 1.25%	84,857 $8.59 Million
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $196,869 - $230,957	-2,071 Reduced 2.35%	85,933 $0
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $469,963 - $544,129	-4,857 Reduced 5.23%	88,004 $8.52 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $185,971 - $224,780	-1,822 Reduced 1.92%	92,861 $10.1 Million
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $163,162 - $198,966	-1,431 Reduced 1.49%	94,683 $11.2 Million
Q4 2021 Jan 25, 2022	BUY	$115.53 - $141.46 $6,700 - $8,204	58 Added 0.06%	96,114 $13.5 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $7.7 Million - $8.52 Million	66,000 Added 219.59%	96,056 $11.3 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $18,301 - $21,543	173 Added 0.58%	30,056 $3.49 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $10,013 - $11,797	-92 Reduced 0.31%	29,883 $3.58 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $49,665 - $54,120	-473 Reduced 1.55%	29,975 $3.28 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $45,545 - $55,311	-497 Reduced 1.61%	30,448 $3.31 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $846,940 - $1.08 Million	-11,061 Reduced 26.33%	30,945 $2.83 Million
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $98,124 - $143,485	-1,562 Reduced 3.59%	42,006 $3.32 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $368,447 - $410,168	4,693 Added 12.07%	43,568 $3.78 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $528,440 - $572,994	6,457 Added 19.92%	38,875 $3.25 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $1,020 - $1,190	-14 Reduced 0.04%	32,418 $2.73 Million
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $3,046 - $3,682	-46 Reduced 0.14%	32,432 $2.59 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $18,160 - $20,572	-277 Reduced 0.85%	32,478 $2.35 Million
Q3 2018 Oct 12, 2018	BUY	$60.81 - $73.36 $3,405 - $4,108	56 Added 0.17%	32,755 $2.4 Million
Q2 2018 Jul 24, 2018	SELL	$57.57 - $63.54 $31,202 - $34,438	-542 Reduced 1.63%	32,699 $1.99 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $1.87 Million - $2.11 Million	33,241 New	33,241 $1.99 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $1.39 Million - $1.48 Million	-25,824 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $1.24 Million - $1.39 Million	25,824	25,824 $1.38 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.

Account

Busey Wealth Management Abbott Laboratories Transaction History